Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-4-9
|
pubmed:abstractText |
Exogenous transforming growth factor-beta 2 (TGF-beta 2) markedly inhibits the interleukin 4 (IL4)-stimulated synthesis of human IgE in three models where the B cell co-stimulation signals are contact dependent. This concerns T cell-dependent IgE production by (i) unfractionated peripheral blood mononuclear cells (PMBC) cultured with IL4 and (ii) highly purified B cells cocultured with irradiated EL4 thymoma cells in the presence of IL4 and phorbol myristate acetate, as well as monocyte-dependent IgE production by rigorously T cell-depleted PBMC cultured with IL4 and hydrocortisone. The suppression is not isotype specific. TGF-beta exerts its effect by inhibiting the proliferation of B cells and perhaps also the differentiation of proliferating B cells. However, at a later stage of differentiation, IgE B cells are refractory to the inhibitory effect of TGF-beta, as shown by the slight but significant increase of the spontaneous secretion of IgE by PBMC of atopic patients. This enhancement is due to the suppression of endogenous interferon-gamma production. Most interestingly the synthesis of IgE by highly purified B cells costimulated with IL4 and Epstein-Barr virus is unaffected by TGF-beta. It is concluded that TGF-beta mainly acts by inhibiting IL4-supported B cell proliferation; however, its effects depend upon the B cell costimulation signals that are required together with IL4 for the induction of IgE synthesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0090-1229
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
277-84
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1311647-Antibody-Producing Cells,
pubmed-meshheading:1311647-B-Lymphocytes,
pubmed-meshheading:1311647-Cell Differentiation,
pubmed-meshheading:1311647-Cell Division,
pubmed-meshheading:1311647-Herpesvirus 4, Human,
pubmed-meshheading:1311647-Humans,
pubmed-meshheading:1311647-Hypersensitivity, Immediate,
pubmed-meshheading:1311647-Immune Tolerance,
pubmed-meshheading:1311647-Immunoglobulin E,
pubmed-meshheading:1311647-Interleukin-4,
pubmed-meshheading:1311647-Lymphocytes,
pubmed-meshheading:1311647-Transforming Growth Factor beta
|
pubmed:year |
1992
|
pubmed:articleTitle |
Modulation of human IgE synthesis by transforming growth factor-beta.
|
pubmed:affiliation |
University of Montreal, Notre-Dame Hospital, Quebec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|